Shoulder Innovation Arrow Prime offers a cementless, metal-back anatomic glenoid with dual-platform interchangeability, designed to reduce glenoid loosening, a common failure mode in total shoulder arthroplasty. Its clinically validated lineage and streamlined four-tray instrument system support intraoperative flexibility and efficiency. This positions FH Ortho as a compelling partner for high-volume shoulder programs and fellowship-trained surgeons seeking cutting-edge solutions. Explore adoption through surgical education, case exemplars, and outcomes data to accelerate clinical uptake.

Calcaneal and Knee Calcanail provides a percutaneous, tissue-sparing intramedullary nail approach for calcaneal pathologies, expanding options for tuberosity displacement, intra-articular fractures, and arthrodesis when indicated. The CoLS soft-tissue knee repair system targets common shortcomings with short tunnels, a pre-tensioned graft, and robust fixation to support healing. Together, these platforms enable trauma and sports medicine teams to broaden surgical indications with potentially faster recoveries. Target mid-market hospitals and fracture clinics with clinical data and surgeon testimonials to demonstrate value.

Channel Expansion FH Ortho has demonstrated channel capability through a distribution partnership with Red One Medical, illustrating potential to reach surgeon networks via SDVOSB aligned channels. There is opportunity to extend partnerships to additional specialty distributors, VA facilities, and community hospitals seeking innovative orthopedic solutions. Deploy coordinated sales education and adoption programs for mid-size health systems and ambulatory surgical centers. Leverage value propositions around surgeon-focused design and efficient instrument systems.

Growth Readiness With a mid-sized team and a growing product portfolio across shoulder, calcaneal, and knee segments, FH Ortho seems well positioned to scale with bundled purchasing and multi-product programs. The compact instrument systems and clear clinical benefits can shorten adoption cycles in busy operating rooms. A multi-region sales push paired with clinical training can accelerate rollout in target centers of excellence. Consider pilot agreements and clinical study sponsorship to build payer-friendly economic cases.

Competitive Positioning FH Ortho is described as a first mover in shoulder arthroplasty innovations and a driver of soft-tissue knee repair advancements, offering differentiated designs and fixation strategies. Glenoid loosening risk is addressed by Arrow Prime, supporting better long-term survivorship in implants. Use these differentiators to engage surgeons seeking reliable, outcome-driven solutions and to justify premium pricing with strong clinical data. Position FH Ortho as an innovation partner for key orthopedic centers and research groups.